Skip to main content
Erschienen in: Virchows Archiv 4/2015

01.04.2015 | Original Article

In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance

verfasst von: Nadine T. Gaisa, Holger Wilms, Peter J. Wild, Gerhard Jakse, Axel Heidenreich, Ruth Knuechel

Erschienen in: Virchows Archiv | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Histological tumor subtyping, staging, and grading are of utmost importance to stratify patients with bladder cancer for treatment and should be as precise as possible. In the presented study, we investigated the prognostic impact of standard clinicopathological parameters in cystectomy patients and compared embedding of the entire bladder with standard partial embedding via a virtual superimposed approach. The study included 121 cystectomy specimens, which were completely embedded. Clinical and histopathological data of patients were obtained (median follow-up 21.5 months; range 1–67 months). For 88 patients two-dimensional tumor maps (macrophotographs and histology-based maps) were prepared, and embedding of the entire bladder was compared with a virtual standard partial embedding, created by a virtual overlay and data extraction of the tumor maps. Kaplan-Meier plots, Cox regression estimators, Chi-square, and McNemar tests were used. In a multivariate Cox regression model for overall survival, only venous invasion (p = 0.008, HR = 3.35, 95 % CI 1.375–8.161) and organ-confined (pTis–pT2) versus non-organ-confined diseases (pT3–pT4; p = 0.021, HR 2.669, 95 % CI 1.157–6.159) were found significant. Advanced versus standard embedding revealed significant improvement in the detection of carcinoma in situ (50 versus 61, p = 0.003) and lymphatic invasion (18 versus 24, p = 0.041), but no significant advantage in the detection of tumor stage, tumor multifocality, or venous invasion (all p > 0.05). TNM classification, including lymphatic and venous invasion, is of utmost importance to stratify patients with advanced invasive bladder cancer. Histopathological details are detected more reliably by whole organ embedding, but this approach showed no significant benefit in terms of outcome-related parameters (max. tumor stage, venous invasion) in our cohort.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Lopez-Beltran A, Sauter G, Gasser T et al (2004) Tumors of the urinary system. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 89–157 Lopez-Beltran A, Sauter G, Gasser T et al (2004) Tumors of the urinary system. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 89–157
3.
Zurück zum Zitat Pan CC, Chang YH, Chen KK et al (2010) Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 133:788–795CrossRefPubMed Pan CC, Chang YH, Chen KK et al (2010) Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 133:788–795CrossRefPubMed
4.
Zurück zum Zitat Cao D, Vollmer RT, Luly J et al (2010) Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 76:593–599CrossRefPubMed Cao D, Vollmer RT, Luly J et al (2010) Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 76:593–599CrossRefPubMed
5.
Zurück zum Zitat Kim HS, Kim M, Jeong CW et al (2014) Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis. Urol Oncol. doi:10.1016/j.urolonc.2014.05.008 Kim HS, Kim M, Jeong CW et al (2014) Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis. Urol Oncol. doi:10.​1016/​j.​urolonc.​2014.​05.​008
6.
Zurück zum Zitat Culp SH, Dickstein RJ, Grossman HB et al (2014) Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol 191:40–47CrossRefPubMedCentralPubMed Culp SH, Dickstein RJ, Grossman HB et al (2014) Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol 191:40–47CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Husillos-Alonso A, Herranz Amo F, Subira-Rios D et al (2013) Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen. Arch Esp Urol 66:787–795PubMed Husillos-Alonso A, Herranz Amo F, Subira-Rios D et al (2013) Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen. Arch Esp Urol 66:787–795PubMed
8.
Zurück zum Zitat Tilki D, Shariat SF, Lotan Y et al (2013) Lymphovascular invasion is independntly associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. BJU Int 111:1215–1221CrossRefPubMed Tilki D, Shariat SF, Lotan Y et al (2013) Lymphovascular invasion is independntly associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. BJU Int 111:1215–1221CrossRefPubMed
9.
Zurück zum Zitat Koss LG, Tiamson EM, Robbins MA (1974) Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. JAMA 227:281–286CrossRefPubMed Koss LG, Tiamson EM, Robbins MA (1974) Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. JAMA 227:281–286CrossRefPubMed
10.
Zurück zum Zitat Koss LG (1979) Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum Pathol 10:533–548CrossRefPubMed Koss LG (1979) Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum Pathol 10:533–548CrossRefPubMed
11.
Zurück zum Zitat Kakizoe T, Matsumoto K, Nishio Y et al (1984) Analysis of 90 step-sectioned cystectomized specimens of bladder cancer. J Urol 131:467–472PubMed Kakizoe T, Matsumoto K, Nishio Y et al (1984) Analysis of 90 step-sectioned cystectomized specimens of bladder cancer. J Urol 131:467–472PubMed
12.
Zurück zum Zitat Theuring F, Theuring U (1990) Systematic histologic urinary bladder mapping in primary urinary bladder cancers. Pathologe 11:148–153PubMed Theuring F, Theuring U (1990) Systematic histologic urinary bladder mapping in primary urinary bladder cancers. Pathologe 11:148–153PubMed
13.
Zurück zum Zitat Sakamoto N, Tsuneyoshi M, Enjoji M (1992) Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases. Histopathology 21:135–141CrossRefPubMed Sakamoto N, Tsuneyoshi M, Enjoji M (1992) Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases. Histopathology 21:135–141CrossRefPubMed
14.
Zurück zum Zitat Hind A, Ventura L, Leocata P et al (1998) Histopathological study of 110 cystectomy specimens for bladder cancer by an original mapping method. J Exp Clin Cancer Res 17:59–64PubMed Hind A, Ventura L, Leocata P et al (1998) Histopathological study of 110 cystectomy specimens for bladder cancer by an original mapping method. J Exp Clin Cancer Res 17:59–64PubMed
15.
Zurück zum Zitat Jozwicki W, Domaniewski J, Skok Z et al (2005) Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: a mapping study. Urology 66:1122–1126CrossRefPubMed Jozwicki W, Domaniewski J, Skok Z et al (2005) Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: a mapping study. Urology 66:1122–1126CrossRefPubMed
16.
Zurück zum Zitat Galosi AB, Cheng L, Lopez-Beltran A et al (2013) Precise morphologic documentation with large-format histology of clinical findings in a bladder cancer patient. Eur Urol 64:519–521CrossRefPubMed Galosi AB, Cheng L, Lopez-Beltran A et al (2013) Precise morphologic documentation with large-format histology of clinical findings in a bladder cancer patient. Eur Urol 64:519–521CrossRefPubMed
17.
Zurück zum Zitat Sükösd F, Ivanyi B, Pajor L (2014) Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy. Pathol Oncol Res 20:677–685CrossRefPubMed Sükösd F, Ivanyi B, Pajor L (2014) Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy. Pathol Oncol Res 20:677–685CrossRefPubMed
18.
Zurück zum Zitat Davidson DD, Cheng L (2006) “Field cancerization” in the urothelium of the bladder. Anal Quant Cytol Histol 28:337–338PubMed Davidson DD, Cheng L (2006) “Field cancerization” in the urothelium of the bladder. Anal Quant Cytol Histol 28:337–338PubMed
19.
Zurück zum Zitat Hansel DE, Amin MB, Comperat E et al (2013) A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. Eur Urol 63:321–332CrossRefPubMed Hansel DE, Amin MB, Comperat E et al (2013) A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. Eur Urol 63:321–332CrossRefPubMed
20.
Zurück zum Zitat D’Souza AM, Pohar KS, Arif T et al (2012) Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy. Virchows Arch 461:467–474CrossRefPubMed D’Souza AM, Pohar KS, Arif T et al (2012) Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy. Virchows Arch 461:467–474CrossRefPubMed
21.
Zurück zum Zitat Rink M, Hansen J, Cha EK et al (2013) Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int 111:74–84CrossRefPubMed Rink M, Hansen J, Cha EK et al (2013) Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int 111:74–84CrossRefPubMed
22.
Zurück zum Zitat Bolenz C, Herrmann E, Bastian PJ et al (2010) Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. BJU Int 106:493–499CrossRefPubMed Bolenz C, Herrmann E, Bastian PJ et al (2010) Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. BJU Int 106:493–499CrossRefPubMed
23.
Zurück zum Zitat Lotan Y, Gupta A, Shariat SF et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533–6539CrossRefPubMed Lotan Y, Gupta A, Shariat SF et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533–6539CrossRefPubMed
24.
Zurück zum Zitat Fritsche HM, May M, Denzinger S et al (2013) Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol 63:739–744CrossRefPubMed Fritsche HM, May M, Denzinger S et al (2013) Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol 63:739–744CrossRefPubMed
25.
Zurück zum Zitat Nuhn P, Bastian PJ, Novara G et al (2011) Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol Int 87:42–48CrossRefPubMed Nuhn P, Bastian PJ, Novara G et al (2011) Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol Int 87:42–48CrossRefPubMed
26.
Zurück zum Zitat Mitra AP, Bartsch CC, Bartsch G Jr et al (2014) Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis. An intensive case–control analysis. Urol Oncol 32:117–127CrossRefPubMed Mitra AP, Bartsch CC, Bartsch G Jr et al (2014) Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis. An intensive case–control analysis. Urol Oncol 32:117–127CrossRefPubMed
27.
Zurück zum Zitat Xylinas E, Rink M, Robinson BD et al (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49:1889–1897CrossRefPubMed Xylinas E, Rink M, Robinson BD et al (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49:1889–1897CrossRefPubMed
Metadaten
Titel
In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance
verfasst von
Nadine T. Gaisa
Holger Wilms
Peter J. Wild
Gerhard Jakse
Axel Heidenreich
Ruth Knuechel
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 4/2015
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-015-1726-7

Weitere Artikel der Ausgabe 4/2015

Virchows Archiv 4/2015 Zur Ausgabe

Editorial

In this issue

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …